TABLE 3.
No. | Compound | IC50 | R1 | R2 | X | R30 | R4 |
---|---|---|---|---|---|---|---|
μm | |||||||
1 | Lysinea | 0.68 ± 0.04 | CH2 | H | |||
2 | Aminoethylcysteine | 0.045 ± 0.003 | S | H | |||
3 | Aminoethylserine | 0.40 ± 0.02 | O | H | |||
4 | (5R)-5-Hydroxylysine | 17.6 ± 0.8 | CH2 | OH | |||
5 | Lysinamide | 620 ± 70 | CONH2 | CH2 | H | ||
6 | Cadaverine | 910 ± 40 | H | CH2 | H | ||
7 | N-α-methyl-lysineb | 1300 ± 120 | CH2 | H | |||
8 | 6-Aminohexanoic acid | >1000 | -H | CH2 | H | ||
9 | Norleucine | >1000 | CH2 | H | H | ||
10 | 4,5-trans-Dehydrolysine | 2.5 ± 0.1 | |||||
11 | Ornithineb | 700 ± 150 | |||||
12 | Arginine | >1000 | |||||
13 | N-Acetylethylenediamine | 6.8 ± 0.9 | |||||
14 | Histamine | 330 ± 20 | |||||
15 | Ethanolamine | 1770 ± 150 | |||||
16 | Glycine | >1000 | |||||
17 | β-Alanine | >1000 |
The apparent inhibition by lysine is the consequence of isotopic dilution of the radiolabeled substrate.
As described in the “Results,” these samples apparently contained contaminating lysine.